Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - lidocaine hydrochloride monohydrate, quantity: 22 mg/g - gel - excipient ingredients: methyl hydroxybenzoate; propylene glycol; hyetellose; purified water - for local anaesthesia and lubrication of mucosa.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections

Australia - English - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - lidocaine hydrochloride monohydrate, quantity: 21.3 g - gel - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; carmellose sodium; purified water; amaranth; flavour - mucosoothe is indicated for the relief of pain and discomfort of mucous membranes of the mouth, pharynx and upper gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.4 mg/ml - oral liquid - excipient ingredients: carmellose sodium; propyl hydroxybenzoate; citric acid; purified water; sodium hydroxide; methyl hydroxybenzoate; saccharin sodium; flavour - indicated for the relief of pain and discomfort associated with:,?irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,?introduction of instruments and catheters into the respiratory and gastrointestinal tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - indicated for the production of local or regional anesthesia by infiltration techniques including percutaneous injection, peripheral nerve block techniques such as brachial plexus & intercostal blocks and central neural techniques including epidural & caudal blocks.